95067 ⎘
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
CANNABINOID DERIVATIVES AND COMPOSITIONS COMPRISING SAME
#2DIHYDROMYRICETIN EXTRACTION AND PURIFICATION PROCESS
#3CHEMICAL SYNTHESIS METHOD OF PRODELPHINIDIN B9 GALLATE
#4SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS
#5CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF PREPARATION THEREOF
#6Method for separating natural substance mixtures by means of SCPC
#7Polyphenol production method
#8Myricetin derivative and preparing method thereof, and application of same for treating colitis, preventing and treating colitis tumorigenesis, and treating colorectal cancer
#9Small molecule compounds targeting PBX1 transcriptional complex
#10PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof
#11Anti-obesity agent comprising compound containing benzotropolone ring
#12CYCLIC PEROXIDE OXIDATION OF AROMATIC COMPOUNDS PRODUCTION AND USE THEREOF
#13Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#14Mitochondrial inhibitors to treat human disease
#15Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound
#16Composition comprising the extract of Bunge or the compounds isolated from the same for preventing and treating lipid metabolism disorder
#17Anti-obesity agent comprising compound containing benzotropolone ring
#18Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#19PREVENTION AND REVERSAL OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
#20NOVEL CHROMENE AND THIOCHROMENE CARBOXAMIDE DERIVATIVES, METHODS FOR PREPARING SAME AND THERAPEUTIC APPLICATIONS OF SAME
#21ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION
#22Treatment of periodontal disease
#23Epicatechin and vasodilation
#24Therapeutic Morpholino-Substituted Compounds
#25Therapeutic morpholino-substituted compounds
#26Treatment of inflammation
#27Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
#28Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#29Hair Growth Stimulants
#30Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
#31Methods and Agents for Inhibiting Dynamin-Dependent Endocytosis
#32Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#33Treatment of pain and fever
#34Glucose levels
#35Renal function improvement
#36Treatment of inflammation
#37Non-steroidal farnesoid x receptor modulators
#38Non-steroidal farnesoid X receptor modulators and methods for the use thereof
#39Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
#40Methods of manufacture and combination compositions
#41SUBSTITUTED 4H-CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
#42Epicatechin for hypertension treatment
#43Treatment of periodontal disease
#44Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#45Benzopyran compounds useful for treating inflammatory conditions
#46Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
#47Non-steroidal farnesoid X receptor modulators and methods for the use thereof
#48Therapeutic morpholino-substituted compounds
#49Treatment of hypertension
#50Method of cannabinoid preservation through crystallization and other crystal structures